Introduction
============

Delirium is an acute or subacute, usually reversible syndrome of impaired higher cortical functions characterized by generalized cognitive disturbance and behavioral problems. The key clinical manifestation of delirium is a rapid change in quality of consciousness and cognition in a short time. Specifically, an excess of dopamine or depletion of acetylcholine has been associated with delirium.[@b1-ndt-12-2425]--[@b4-ndt-12-2425] Moreover, central nervous system regulation, changes in a peripheral fluid, electrolyte homeostasis, and functional cardiovascular abnormalities can accompany and modify clinical symptoms of delirium.[@b5-ndt-12-2425],[@b6-ndt-12-2425]

Studies conducted in various medical and surgical inpatients have demonstrated that 15%--70% of subjects experienced delirium at some point during their hospital stay.[@b7-ndt-12-2425]--[@b9-ndt-12-2425] Reported prevalence among acute intensive care unit (ICU) is even higher, between 78% and 87% of patients, especially in elderly.[@b8-ndt-12-2425],[@b10-ndt-12-2425]--[@b12-ndt-12-2425] Many individuals with this condition would be expected to have improvement in their symptoms with specific treatment of the medical conditions that likely led to the onset of delirium.[@b13-ndt-12-2425],[@b14-ndt-12-2425] Nearly one-third of patients admitted to ICU develop delirium.[@b15-ndt-12-2425] These patients are at increased risk of death during admission, longer stays in hospital, and cognitive impairment after discharge.[@b15-ndt-12-2425]

Risk factors
------------

Despite the fact that delirium is a very common problem, prospective studies examining the risk factors have been performed relatively rarely. Nevertheless, several studies, reviews, and meta-analyses have examined the risk factors for delirium in the ICU in the last 5 years.[@b6-ndt-12-2425],[@b16-ndt-12-2425]--[@b24-ndt-12-2425] These investigations indicate that older age, the severity of somatic illness, hypertension, alcoholism, dementia, increased volume load during surgery, risk of infection, sensory impairment, urinary catheterization, electrolyte imbalance, malnutrition, low albumin level, use of analgesics or sedatives are associated with increased risk of delirium. Delirium is independently associated with several serious adverse outcomes including increased morbidity, mortality, likelihood of discharge to a nursing home, longer length of ICU and hospital stays, and higher medical costs.[@b16-ndt-12-2425],[@b18-ndt-12-2425],[@b22-ndt-12-2425]--[@b30-ndt-12-2425] Delirium is a predictor of 6-month mortality in cases of patients who are mechanically ventilated.[@b30-ndt-12-2425] Delirium is experienced as distress by patients, their caregivers, and nursing staff also.[@b31-ndt-12-2425] Patients admitted to an ICU have many nonmodifiable risk factors for delirium such as age, severity of physical illness, and dementia. Alcohol abuse, other illicit drugs, and use of psychoactive medication are the potentially modifiable risk factors for delirium.

Duration of delirium in ICU
---------------------------

Some investigations have examined the length of delirium in ICU.[@b32-ndt-12-2425]--[@b34-ndt-12-2425] Patients with longer ICU stays have increased risks for acquiring nosocomial infections and other ICU-related complication factors for delirium.[@b35-ndt-12-2425] Reducing delirium duration is a critical issue in the assessment of the effectiveness of any delirium intervention. Observational studies have shown that delirium is frequently a transient syndrome with the rapid treatment of precipitating medical illness. Several studies have found that delirium in postoperative populations lasted between 1 day and 4 days in most cases.[@b36-ndt-12-2425]--[@b42-ndt-12-2425] Other studies have found a more protracted course of delirium, especially in cancer populations[@b40-ndt-12-2425],[@b43-ndt-12-2425] and elderly.[@b44-ndt-12-2425],[@b45-ndt-12-2425]

The role of psychoactive medication in the treatment of delirium
----------------------------------------------------------------

Psychoactive medications are used in managing the majority of delirium cases as confirmed by surveys of psychiatrist and intensive care physicians.[@b46-ndt-12-2425],[@b47-ndt-12-2425] The most frequently used drugs are the typical antipsychotics: haloperidol, tiapride, melperone; second-generation antipsychotics; benzodiazepines; or clomethiazole in the case of alcohol withdrawal delirium.[@b30-ndt-12-2425],[@b42-ndt-12-2425],[@b46-ndt-12-2425],[@b48-ndt-12-2425]--[@b50-ndt-12-2425] Although several studies have found that exposure to psychoactive medications, including antipsychotics, poses a risk for the subsequent development of delirium; on the other side, many of these studies did not establish the crucial relationship between delirium onset and use of antipsychotics.[@b36-ndt-12-2425],[@b42-ndt-12-2425],[@b50-ndt-12-2425]--[@b52-ndt-12-2425] Pisani et al[@b53-ndt-12-2425] had shown that receipt of benzodiazepines before ICU admission was associated with delirium within the first 48 hours of ICU admission. Researchers have also found the use of these medications as a risk factor for transitioning to delirium.[@b17-ndt-12-2425]

With regard to efficiency of individual antipsychotics, comparison trials had not identified any particular antipsychotic medication as superior to another.[@b50-ndt-12-2425] The observed improvements in delirium severity tended to occur within the first week of treatment using conservative dosing strategies.[@b54-ndt-12-2425] In a retrospective study of delirium in cancer patients, Olofsson et al[@b43-ndt-12-2425] described that patients who received haloperidol had a shorter duration of delirium compared with those who did not. In contrast, a prospective study by Manos and Wu[@b55-ndt-12-2425] and also a meta-analysis by Neufeld et al[@b42-ndt-12-2425] found that the length of delirium was significantly longer in persons referred for psychiatric consultation when they were treated with haloperidol as compared with those who did not. In a retrospective study in ICU, Milbrandt et al[@b56-ndt-12-2425] reported that patients who received haloperidol had significantly reduced mortality over those who did not. In contrast, the other study[@b57-ndt-12-2425] showed no significant difference in the incidence of postoperative delirium low-dose preoperative and postoperative haloperidol treatment to prevent delirium in elderly hip surgery patients.

Types of delirium
-----------------

It has been shown that hyperactive delirium may be associated with a better prognosis than hypoactive delirium.[@b28-ndt-12-2425],[@b44-ndt-12-2425],[@b58-ndt-12-2425] Individuals with hyperactive delirium are also more likely to receive antipsychotic medications.[@b59-ndt-12-2425] Hyperactive delirium may get patients at higher risk for adverse events due to disruptive behaviors such as combativeness, wandering, and other behaviors that interfere with medical care such as restlessness and agitation ending in patients manipulating with the endotracheal tubes, intravenous lines, etc.

Aim of the study
----------------

The purpose of this study was to examine the impact of the type of delirium, its possible causative factors, electrolyte imbalance, medication, physical comorbidities, such as anemia, hypotension, and more of other cofactors on the duration of Central Intensive Care Unit for Surgery (CICUS) delirium. The aim of this study was to identify which characteristics are most strongly associated with duration of delirium.

According to the hypotheses, there might be differences between duration of delirium related to 1) demographic data, eg, age and sex; 2) subtypes of delirium: hyperactive, hypoactive, mixed; 3) history of alcohol abuse; 4) patients with cancer versus patients without cancer; 5) hyperthermia; 6) hypoalbuminemia; 7) circulatory and pulmonary dysfunction (failure); 8) type of psychoactive medication; and 9) electrolyte imbalance.

Patients and methods
====================

Study participants were 140 consecutive delirious patients (mean age: 68.21±12.07 years, 71.4% males) admitted to the Department of Central Intensive Care Unit for Surgery in the University Hospital Olomouc from February 2004 to November 2008. More than 90% of all patients were admitted after major elective surgery. They were selected according to the complexity of complications during surgery or according to the severity of their comorbidities. Only a less number of patients were admitted after acute surgery. Some of the patients (after a complicated surgery or those with severe medical history) were mechanically ventilated or planned for delayed extubation postoperatively. Others received oxygen supplementation by the face mask. The blood pressure (IBP or NIBP), heart rate, respiratory rate, peripheral oxygen saturation, and body temperature were monitored continuously. The analgesics (mostly opiates), fluid therapy, and other intravenous drugs were administered. Complex laboratory tests including bedside blood gasses analysis were available, and all disturbances present were corrected immediately. The Glasgow Coma Scale, Sepsis-related Organ Failure Assessment Score, and Acute Physiology and Chronic Health Evaluation II scores were recorded in all the patients admitted in SICU, and the Riker sedation--agitation scale (Riker SAS) and Richmond agitation--sedation scale (RASS) were used in patients with psychiatric history, neurological alterations, with disorientation or patients with delirium.

Of 5,642 admitted patients, a total of 203 patients were diagnosed with severe delirium, and finally, 140 patients met the inclusion criteria and were enrolled in the study. In this study, the cut point for enrollment was at least 12 hours of duration of the delirium. Of the 63 nonenrolled patients, 51 patients did not complete the criterion of minimum time in the CICUS, 12 patients were excluded from further analysis due to the persistently low level of consciousness or coma. One patient died (0.71%). Informed consent had been acquired from the patients just before the surgery at the time of admission to the University Hospital Olomouc. Second consent was obtained after the delirium subsided and according to consent consensus approved by the University Hospital Olomouc Committee.

Assessment
----------

Medical records were studied to get an admitting diagnosis. The components of routine laboratory measurements that were examined included body temperature, mean blood pressure, heart rate, respiratory rate, serum sodium level, potassium level, chlorides, creatinine level, full blood count, white blood cell count, C-reactive protein (CRP), phosphorus, proteins, albumin, and laboratory markers of renal and liver dysfunction. Clinically meaningful thresholds were used to categorize physiological variables as abnormal, and these cut points are presented in [Table 1](#t1-ndt-12-2425){ref-type="table"}.

The status of the patient was evaluated by the physicians three times a day. Nurses performed the chart scales, monitored the clinical state of the patients, and recorded administrated medication.

Delirium was assessed using the validated chart review methods four times a day (every 6 hours). The physicians made the initial diagnosis according to the clinical picture of the patient and Riker SAS and RASS were used as additional tools for confirming the diagnosis. The outcome -- variable duration of delirium -- was the length of the delirium measured in hours. Delirium was defined as a sequence of consecutive hours of delirium as assessed by the chart review. Likewise, if a nondelirium or coma day occurred in between delirium days, the nondelirium day was included in the delirium episode. Each studied episode ended when there were 48 consecutive hours without delirium.

The predictor variables such as types of delirium, primary somatic disorder, complications, electrolytes imbalance, anemia, hypoproteinemia, hypotension, age, sex, cancer, alcohol, nicotine or illicit drugs dependence, and type of used psychoactive medication were correlated with the duration of delirium. Cut points corresponded with the physiological range ([Table 1](#t1-ndt-12-2425){ref-type="table"}).

Treatment approaches
--------------------

The attending physician carried choice of the drugs. All types, dosages, and routes of administration of medication were recorded.

Statistics
----------

Statistics were calculated using GraphPad Prism 5.0 and SPSS 24. Demographic and clinical characteristics were analyzed using descriptive statistics. Normal distribution of the demographic and clinical variables was determined by the Shapiro--Wilk *W*-test. The *χ*^2^ test or Fisher's exact test was used for the analyses of categorical data. Relationships between variables were examined by Pearson's or Spearman's correlation coefficient and backward stepwise multiple regression. Bonferroni correction was added to the regression to lower the probability of false-positive results. The effect of size of the multiple linear regression analysis was calculated using the f2 indicator or its equivalents. The statistical significance threshold was set at 5%.

Results
=======

Demography
----------

Characteristics of the study population are presented in [Table 2](#t2-ndt-12-2425){ref-type="table"}. The mean age of the participants was 68.21±12.07 years. A total of 71.4% of patients were male. The median duration of SICU delirium was 48 hours, with a range of 12--240 hours and mean duration of 65.61±38.09 hours. One patient died (0.71%). (A 61-year-old male, who was presented with alcohol-withdrawal delirium, after transfer to another department, in who respiratory distress emerged, died of respiratory failure.)

The drug data
-------------

The drug data for this study are presented in [Table 3](#t3-ndt-12-2425){ref-type="table"}. The majority of patients received the antipsychotics (72.1%), benzodiazepines (8.6%), piracetam, and few of them other types of medications such as clonidine and citalopram (17.9%). Eight patients were treated with propofol together with an opioid. The majority of patients received just one of the drugs, as a monotherapy, not a combination of them. However, 44 patients had some type of a drug combination, nine (midazolam and tiapride), two (clonazepam and tiapride), five (propofol and tiapride), three (propofol and haloperidol), nine (piracetam and tiapride), seven (diazepam and tiapride), five (clonidine and tiapride), one (alprazolam and tiapride), one (olanzapine and tiapride), one (haloperidol and tiapride), and one (melperone and haloperidol). Reasons for combinations were a high degree of agitation or the necessity of a mechanical restriction. Two patients switched from benzodiazepines to antipsychotics due to increased risk of a respiratory problem. The opioids used in 111 patients, are more questionable, because they probably contribute most to the extension of the delirium. The same can be claimed for antibiotics used in 96 patients.

Treatment outcome
=================

Fully resolved delirium can be detected after 12--240 hours with a median of 48 hours and mean of 65.61±38.09 hours. The mean duration of the delirium in females (n=40) was 58.15±30.47 hours and in males (n=100) was 68.57±40.48 hours, there were no statistical differences found (Mann--Whitney *U*=1,640: ns).

Comparison of different types of delirium
-----------------------------------------

Three clinical subtypes of delirium, based on arousal disturbance and psychomotor activity, have been described. These subtypes included the "hyperactive" (agitated) subtype, the "hypoactive" (lethargic) subtype, and a "mixed" subtype with alternating features of hyperactive and hypoactive delirium. There were statistically significant differences in the meantime for the duration of delirium according to its subtype. The average length of hyperactive subtype was 76.15±40.53 hours, in hypoactive subtype 54.46±28.44 hours, and in mixed subtype 61.22±37.86 hours (Kruskal--Wallis test: 8.022; *P*\<0.05). Dunn's multiple comparison tests showed the difference between hyperactive and hypoactive delirium (*P*\<0.05). All the three clinical subtypes of delirium were not statistically different in other parameters such as age (hyperactive: 65.44±11.77 years; hypoactive: 69.3±15.31 years; mixed: 70.25±10.28 years; one-way analysis of variance \[ANOVA\]: *F*=2.42, *df* =139; *P*=0.0927), plasma CRP, potassium, chlorides, proteins, albumins (all one-way ANOVA, ns), but there was a statistical difference in the levels of phosphorus (hyperactive: 0.85±0.33; hypo-active: 1.28±0.52; mixed 0.88±0.33; one-way ANOVA: *F*=2.42, *df*=139; *P*\<0.005) with Tukey's Multiple Comparison Test showed differences between hypoactive delirium and both other subtypes (both: *P*\<0.05).

Comparison of different clinical conditions
-------------------------------------------

There were no statistically significant differences in the duration of delirium in patients with hyperpyrexia, carcinoma, circulatory and pulmonary failure, need for reintubation, preexisting psychiatric diagnosis, and anemia or hypoproteinemia compared with patients without these conditions ([Table 4](#t4-ndt-12-2425){ref-type="table"}). Nevertheless, there were statistically significant differences in duration of delirium in patients with and without hypotension and with and without a history of alcohol abuse.

Comparison of laboratory findings
---------------------------------

The duration of delirium did not correlate with the values of plasma hemoglobin (in grams per liter), CRP (in milligrams per liter), sodium, phosphorus, and chloride levels (all in millimoles per liter), with proteinemia or with albuminemia (both in grams per liter). However, the duration of delirium did significantly correlate with plasma potassium levels (in milligrams per liter; Pearson's *r*=0.2189, *P*\<0.05). Linear regression between plasma potassium level and duration of the delirium in hours is highly statistically significant ([Figure 1](#f1-ndt-12-2425){ref-type="fig"}).

Comparison of types of psychoactive medication
----------------------------------------------

There were statistically significant differences (Kruskal--Wallis test: 17.39, *P*\<0.0005) in duration of delirium in groups treated with antipsychotics (n=101, mean =72.83±40.6 hours), with benzodiazepines (n=12, mean =42.00±20.78 hours), and the group treated with other drugs (n=23, mean =46.96±18.42 hours).

For more detailed understanding, the three largest subgroups were compared according to the medication (typical antipsychotics n=99; anxiolytics n=13; and piracetam n=17). There was statistically significant difference (Kruskal--Wallis: 13.27; *P*\<0.005) in the duration of delirium in patients treated with typical antipsychotics (mean =70.67±37.00 hours) versus anxiolytics (mean =42.46±19.97 hours) but not versus piracetam (mean =49.41±19.85 hours). The comparison of the somatic illnesses and complications and the types of delirium in these three subgroups is shown in [Table 5](#t5-ndt-12-2425){ref-type="table"}. The group treated with anxiolytics was significantly younger than the group treated with antipsychotics. There were significantly higher numbers of patients with a hyperactive form of delirium in an antipsychotic group than in two other groups.

Regression analysis
-------------------

Various factors are significantly associated with the duration of the delirium. Hence, multiple regression analyses were performed. Backward stepwise regression identified the most important factors linked to the duration of delirium as the dependent variable. The independent variables, which entered, to the regression analysis, were types of delirium, plasma potassium level, plasma chlorides level, anemia, albuminemia, hyperpyrexia, hypotension, history of alcohol abuse, hepatic failure, type of psychoactive drugs and their dosages, use of a combination of psychopharmacs, administration of antibiotics, type of delirium, the daily dosage of opioids (calculated to morphine index), and cardiopulmonary resuscitation in ICU.

The backward stepwise regression consisted of seven steps. Hypotension, type of psychopharmacs, type of delirium, the daily dosage of opioids, a combination of psychopharmacs, and alcohol abuse history, plasma potassium level, anemia values, hyperpyrexia, and albuminemia reached statistical significance. The subsequent model explained 63.7% of the dependent variable (*P*\<0.001; [Table 6](#t6-ndt-12-2425){ref-type="table"}).

Discussion
==========

The incidence of delirium in the ICU (2.5%) was much less than that is usually quoted for surgical inpatient (typically between 15% and 70%).[@b8-ndt-12-2425],[@b10-ndt-12-2425]--[@b12-ndt-12-2425] The reason for the difference between another statistic from ICU setting is unknown but could be attributed to the fact that most patients in this ICU were young people without a recent history of complicated surgery. The question is about the ICU admission criteria in different countries.

The average duration of the delirium (2--3 days) in this study corresponds with the findings reported by other ICU delirium studies.[@b27-ndt-12-2425],[@b32-ndt-12-2425]--[@b34-ndt-12-2425] One patient had died due to respiratory failure, with complicated postoperative hypostatic pneumonia (patient with hypoactive subtype). Previous studies[@b21-ndt-12-2425],[@b60-ndt-12-2425]--[@b64-ndt-12-2425] have examined risk factors for delirium; however, this study is distinctive in focusing on factors that may influence the duration of the delirium in CICUS.

Dehydration has been documented to be a risk factor for delirium in non-ICU populations.[@b60-ndt-12-2425],[@b65-ndt-12-2425],[@b66-ndt-12-2425] In this study, dehydration was not associated with longer delirium. A previous study[@b67-ndt-12-2425] has documented that early correction of dehydration is associated with prevention of delirium. Studies in the ICUs have demonstrated that rapid and aggressive volume resuscitation can decrease mortality from sepsis, but these studies did not evaluate delirium at all.[@b68-ndt-12-2425] With the establishment of early goal-directed fluid therapy, dehydration may be less significant as a risk factor for prolonged delirium in CICUS. Several variables were significantly linked to the length of delirium, including the type of delirium (hyperactive), mean arterial pressure (hypotension), and higher potassium level and alcohol abuse history in unadjusted analysis. Higher doses of antipsychotics and the combination of psychopharmacs were connected with longer duration of delirium. The results are in agreement with the other study carried out in the psychiatric department with patients with delirium tremens.[@b69-ndt-12-2425] The longest duration of delirium was detected in the group treated with antipsychotics than in the group treated with benzodiazepines. Higher age could cause this prolongation in this group significantly. However, this explanation is insufficient to interpret statistically shorter duration of delirium in patients treated with other drugs (preferably with piracetam) and being of the same age. There may be two other explanations: antipsychotics prolonged the duration of delirium or conversely antipsychotics were administered to patients in more severe condition. In fact, in this study, benzodiazepines were not administered to elderly patients with severe somatic diseases and in the case of high risk of respiratory or cardiac failure. The data are not sufficient to answer this question.

Benzodiazepines could cause a higher risk of respiratory failure in elderly, severe somatic ill patients. So, antipsychotics were preferred to be administered to these risk patients. It is supposed that this was the reason of prolonged delirium duration in the antipsychotics group. Benzodiazepines were also used in some patients with a hypoactive subtype of delirium. These patients were intubated and artificially ventilated, so respiratory depression did not threaten.

Many factors that arise during the CICUS stay undoubtedly contributed to the development and duration of delirium. Multiple regression analysis showed that hypotension, type of psychoactive agents, type of delirium, the daily dosage of opioids, a combination of psychopharmacs, history of alcohol abuse, plasma levels of potassium, anemia, hyperpyrexia, and albuminemia contribute to the duration of delirium.

Limitation of the study
-----------------------

One of the main limitations is the fact that we excluded patients with shorter duration of symptoms of delirium than 12 hours. It was recognized that it is important to differentiate between state after general anesthesia and real symptoms of delirium, which could be a mimicked state after general anesthesia. On the other side, many patients with short delirium, who had recovered rapidly were missed. This selection could influence the mean duration of delirium in the results. Another limitation was that sample size was not calculated prior to start of the study, so there is a risk of statistical error. The efficacy of the treatment stays was questionable due to the absence of blinded placebo group. The possibility to generalize these findings needs to be examined further in the following studies. The study was focused on the factors routinely measured or evaluated in ICU in Czech condition. However, there would be other factors, outside of routine, which could influence the duration of delirium, such as levels of neurotransmitters and hormones. Assessment of delirium severity is another problem. At the time of the realization of the study, the only standardized instrument was Riker SAS and RASS in Czech Republic. Therefore, it would be better to use CAM-ICU in the future studies, which was translated and standardized in the Czech Republic now.

Future studies are also needed to examine the factors, such as psychoactive drug use, invasive procedures, and sleep--wake cycle disruption, during the ICU stay and to examine their further contribution to baseline risk.[@b70-ndt-12-2425]

Conclusion
==========

Delirium is a frequent complication in ICU patients. It is an important condition associated with a number of significant issues and thus deserves its focused treatment, in addition to the management of actual medical conditions. Admission characteristics can be valuable markers for the duration of the delirium in these patients. The hyperactive type of delirium, hypotension, higher plasma potassium level, alcohol abuse in history, and antipsychotic medication in the SICU are associated with longer duration of delirium according to the data. Delirium brings with it an enormous morbidity and mortality burden -- but it represents an incredibly complex condition, and the need to design methods and research to try and crack this complexity. Knowledge of these risk factors could lead to early corrections of metabolic abnormalities and may subsequently reduce the duration of delirium and its complications.
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![Linear regression of plasma potassium level (mmol/L) and duration of delirium (hours).\
**Note:** Linear regression: *t*=19.96, *df*=130.0, *P*\<0.0001.](ndt-12-2425Fig1){#f1-ndt-12-2425}

###### 

Laboratory markers

  Variable                    Physiological range                Number of patients   Number of patients below the threshold/% of patients   Number of patients in normal range/% of patients   Number of patients above the threshold/% of patients
  --------------------------- ---------------------------------- -------------------- ------------------------------------------------------ -------------------------------------------------- ------------------------------------------------------
  Anemia by ERY               ERY 4.0--5.80×10^−12^              140                  122/87.14                                              18/12.86                                           0/0
  Anemia in study Hb in g/L   Hb \<120 g/L                       140                  122/87.14                                              18/12.86                                           0/0
  Peripheral patients body    Body temperature: 35.5°C--38.0°C   140                  22/15.71                                               99/70.71                                           19/13.59
  temperature/axillary        Hyperthermia \>38.0°C                                                                                                                                             
  CRP                         0--10.0 mg/L                       63                   0                                                      0                                                  63/100
  Hypotension                 MAP \<65 Torr (IBP)                140                  44/31.43                                               96/68.57                                           0/0
  Sodium                      130--144 mmolL                     135                  10/7.41                                                118/87.41                                          7/5.19
  Potassium                   3.6--5.4 mmol/L                    134                  14/10.45                                               117/87.31                                          3/2.24
  Phosphates                  0.8--1.6 mmol/L                    64                   22/34.38                                               36/56.25                                           6/9.38
  Chlorides                   95--110 mmol/L                     135                  2/1.48                                                 122/90.37                                          11/8.15
  Proteinemia                 65.0--85.0 g/L                     50                   47/94                                                  3/6                                                0/0
  Albuminemia                 35.0--50.0 g/L                     48                   44/91.67                                               4/8.33                                             0/0

**Abbreviations:** Hb, hemoglobin; CRP, C-reactive protein; ERY, erythrocytes number; MAP, minimal arterial pressure; IBP, invasive blood pressure.

###### 

Main demographic and clinical data

  --------------------------------------------------- -------------------------------------------------
  Age (years)                                         68.21±12.07
  Sex: female:male                                    40:100
  Preexisting psychiatric diagnosis, n (%)            20 (14.3)
  Somatic diseases, n (%)                             
   Cancer                                             86 (61.4)
   Alcohol abuse                                      29 (20.7)
   Other dependency                                   27 (19.3)
   Heart failure                                      9 (6.4)
   Lung failure                                       28 (20)
   Liver failure                                      4 (2.9)
   Kidney failure                                     1 (0.71)
   Polytrauma                                         5 (3.6)
   Head injury                                        6 (4.3)
   Hyperpyrexia (\>38°C)                              19 (13.6)
   Anemia (defined as hemoglobin \<120 g/L)           122 (87.1)
   Hypotension (medium arterial pressure \<70 Torr)   44 (31.4)
   Hypoproteinemia (\<65 g/L)                         48 (34.3)
  Number of patients and mean dosage of:              
   Benzodiazepines (in milligram of diazepam)         12 (35.83)
   Opioids (mean index in milligram of morphine)      108 (39.30)
   Antipsychotics (in milligram of haloperidol)       101 (12.03)
   Propofol                                           8 (continuous infusion, average 1,000 mg daily)
  Subtypes of delirium, n (%)                         
   Hyperactive                                        54 (38.6)
   Hypoactive                                         27 (19.3)
   Mixed                                              59 (42.1)
  --------------------------------------------------- -------------------------------------------------

###### 

Psychoactive medication

  Drug              Patients, n (%)   Mean milligram dosage
  ----------------- ----------------- --------------------------------
  Tiapride          85 (60.7)         589
  Haloperidol       9 (6.4)           15.45
  Melperone         5 (3.6)           100
  Olanzapine        2 (0.7)           15
  Antipsychotics    101 (72.1)        11.84 (haloperidol equivalent)
  Midazolam         2 (1.4)           37.50
  Alprazolam        1 (0.7)           1
  Diazepam          7 (5)             12.14
  Bromazepam        1 (0.7)           3
  Clonazepam        1 (0.7)           1.50
  Benzodiazepines   12 (8.6)          35.83 (diazepam equivalent)
  Zolpidem          1 (0.7)           10
  Clonidine         6 (4.3)           0.40
  Piracetam         17 (12.1)         2,624
  Citalopram        1 (0.7)           20
  Others            25 (17.9)         

###### 

Delirium duration according to complicating conditions and laboratory factors

                       Hyperpyrexia                            Hypotension                                  Carcinoma                                                                       
  -------------------- --------------------------------------- -------------------------------------------- ------------------------------------ --------------------- -------------------- --------------------
  Duration ± SD        62.32±30.66 hours                       87.33±67.10 hours                            70.47±54.98 hours                    40.41±30.23 hours     66.57±37.84 hours    65.00±38.46 hours
  Statistics           Mann--Whitney *U*=898; ns               Mann--Whitney *U*=1,512; ***P***\<**0.05**   Mann--Whitney *U*=2,156; ns                                                     
                                                                                                                                                                                            
                       **Circulatory and pulmonary failure**   **Reintubation**                             **Alcohol abuse**                                                               
  **No (n**=**109)**   **Yes (n**=**28)**                      **No (n**=**118)**                           **Yes (n**=**19)**                   **No (n**=**78)**     **Yes (n**=**59)**   
                                                                                                                                                                                            
  Duration ± SD        61.32±31.38 hours                       82.29±54.82 hours                            64.17±36.17 hours                    74.53±48.59 hours     59.54±30.61 hours    73.63±45.20 hours
  Statistics           Mann--Whitney *U*=1,202; ns             Mann--Whitney *U*=1,010; ns                  Mann--Whitney *U*=1,840; *P*\<0.05                                              
                                                                                                                                                                                            
                       **Preexisting psychiatric diagnosis**   **Anemia**                                   **Hypoproteinemia**                                                             
                       **No (n**=**118)**                      **Yes (n**=**19)**                           **No (n**=**18)**                    **Yes (n**=**119)**   **No (n**=**90)**    **Yes (n**=**47)**
                                                                                                                                                                                            
  Duration ± SD        64.78±35.54 hours                       70.74±52.14 hours                            62.00±28.59 hours                    66.15±39.39 hours     64.93±36.02 hours    66.89±42.15 hours
  Statistics           Mann--Whitney *U*=1,120; ns             Mann--Whitney *U*=1,047; ns                  Mann--Whitney *U*=2,104; ns                                                     

**Abbreviations:** ns, not significant; SD, standard deviation.

###### 

Clinical characteristics of subgroups treated with different medications

  Treatment subgroup       N    Duration of delirium (hours)   Age (years)                Subtypes of delirium: hyper/hypo/mixed   Oncological, yes:no   Alcohol dependency, yes:no   Temperature (°C), yes:no   Psychiatric history, yes:no   Reintubation, yes:no
  ------------------------ ---- ------------------------------ -------------------------- ---------------------------------------- --------------------- ---------------------------- -------------------------- ----------------------------- ----------------------
  Typical antipsychotics   99   70.67±37.00                    69.08±11.52                44:11:44                                 63:33                 19:80                        16:83                      11:88                         10:89
  Anxiolytics              13   42.46±19.97                    60.46±14.41                2:6:5                                    8:5                   4:13                         0:13                       7:6                           1:12
  Piracetam                17   49.41±19.85                    71.53±11.56                1:9:7                                    8:9                   1:16                         0:17                       0:17                          6:11
  Statistics                    Kruskal--Wallis: *P*\<0.005    One-way ANOVA: *P*\<0.05   *χ*^2^: *P*\<0.0001                      *χ*^2^: ns            *χ*^2^: ns                   *χ*^2^: *P*=0.0628         *χ*^2^: *P*\<0.0001           *χ*^2^: *P*\<0.05

**Abbreviation:** ANOVA, analysis of variance.

###### 

Multiple regression analysis with the duration of delirium as a dependent variable

  Model   Regressors                      B        SE      β       T       Significance
  ------- ------------------------------- -------- ------- ------- ------- --------------
  7       Hypotension                     54.72    19.14   0.52    2.86    0.013
          Type of psychopharmacs          10.18    2.17    0.73    4.68    0.000
          Type of delirium                −22.98   7.85    −0.48   −2.93   0.011
          Daily dosage of opioids         1.34     0.43    0.43    3.09    0.008
          Combination of psychopharmacs   57.94    13.98   0.60    4.14    0.001
          History of alcohol abuse        46.64    16.23   0.46    2.87    0.012
          Blood levels of potassium       37.49    17.09   0.36    2.19    0.046
          Anemia                          1.30     0.46    0.44    2.83    0.014
          Hyperpyrexia                    93.32    22.15   0.78    4.21    0.001
          Albuminemia                     4.99     1.97    0.52    2.54    0.024

**Notes:** ANOVA: *F*=5.205; *df*=24; *P*\<0.005. Adjusted *r*^2^=0.637.

**Abbreviations:** SE, standard error; ANOVA, analysis of variance.
